The compound can then be delivered through injection, infusion, inhalation, or ingestion ... also experiencing a surge of interest, antibody-drug conjugates (ADCs). However, there is a difference ...

Merck KGaA said it’s in advanced talks to purchase SpringWorks Therapeutics Inc., sending shares of the US cancer and rare ...

Hard on the heels of the disclosure that Merck KGaA is talking to SpringWorks ... awarded as an incentive to carry out drug development for a rare paediatric disease, that can be used to reduce ...

Germany’s Merck KGaA is in advanced talks for a potential acquisition of SpringWorks Therapeutics, a U.S. biopharmaceutical ...

After a slow 2024, dealmaking in the U.S. healthcare sector is picking up. Springworks has a market value of $3 billion.

On Monday, Germany-based Merck KGaA (OTC:MKGAF ... have the potential to help counter revenue losses from expiring drug patents and increased competition. Price Action: SWTX stock is down ...

Shares of Merck and Pfizer are way down from their previous peaks. Merck's lead drug, Keytruda, grew sales by 19% last year, but its era of patent-protected exclusivity is approaching its end.

Merck’s U.S. subsidiary, Merck & Co., acquired Yale-spinout Modifi Biosciences, a New Haven startup that focuses on developing cancer therapies, in a $1.3 billion deal in October.

Artificial intelligence could be used to prescribe medications to patients — if a new bill makes its way through Congress ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

inactivated Vaqta (Merck) 12 mo at 37 °C Manufacturer Hepatitis B immune globulin (human) Hyperhep B S/D (Bayer) Cumulative exposure for 7 days Manufacturer Hepatitis B vaccine (recombinant ...